Evidence map›Paper›PMID 41141821›Full record

ReviewACS omega2025

Molecular Covalent Functionalization of Graphene and Its Derivatives: An Effective Strategy to Boost Electrocatalytic HER.

Shivani, Xuan Thang Cao, Pavel Kopel, Subodh Kumar

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. RSC advances · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

ShivaniDepartment of Inorganic Chemistry, Faculty of Science, Palacký University Olomouc, 17 Listopadu 12, 77146 Olomouc, Czech Republic.
Xuan Thang CaoFaculty of Chemical Engineering, Industrial University of Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam.ORCID https://orcid.org/0000-0002-4481-9814
Pavel KopelDepartment of Inorganic Chemistry, Faculty of Science, Palacký University Olomouc, 17 Listopadu 12, 77146 Olomouc, Czech Republic.
Subodh KumarDepartment of Inorganic Chemistry, Faculty of Science, Palacký University Olomouc, 17 Listopadu 12, 77146 Olomouc, Czech Republic.ORCID https://orcid.org/0000-0001-8872-2785

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene-based electrocatalysts have been developed, and they exhibited enhanced activity due to their superior electronic conductivity. The robustness of such graphene materials can be further enhanced by altering their chemical and physical properties using different techniques. Molecular covalent functionalization is one of the effective strategies to alter the chemical composition, electronic structure, surface area, as well as dispersibility of graphene materials. Despite the significant literature on its contribution to improving the electrocatalytic activity for the hydrogen evolution reaction (HER), there is no review article available. Therefore, we have tried to fill this void by examining recent developments in the field of molecular covalent functionalized graphene and its derivatives for water electrolysis. We have also thoroughly discussed the role of individual components (graphene support, linker, and functional molecules bearing the main active sites) to improve the performance of the electrocatalyst by inducing synergistic effects and enriching surface properties. Moreover, the main characteristics of effective electrocatalysts, such as the surface area, functionality, dispersibility, conductivity, stability, and electronic structure, have also been reviewed. Finally, challenges and future perspectives are outlined to assist researchers in designing more effective electrocatalysts for the HER.

Identifiers

PMID41141821
PMCPMC12547768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.